Namita Thapar – Executive Director - Emcure Pharmaceuticals Limited of Emcure Pharma
View Detailed Executive Profile →Professional Overview
- Namita Thapar serves as the Executive Director of Emcure Pharmaceuticals, a leading pharmaceutical company in India, where she has been instrumental in managing the company's India business since January 2007.
- Under Thapar's leadership, Emcure Pharmaceuticals has expanded its product portfolio and market presence, contributing significantly to the healthcare sector in India.
- Thapar is a prominent investor on the television show 'Shark Tank India', where she has invested in over 100 startups, showcasing her commitment to fostering entrepreneurship and innovation.
- In addition to her role on 'Shark Tank India', Thapar has established an entrepreneurship academy aimed at empowering teenagers with business skills and knowledge.
- Thapar actively promotes women's health awareness through her YouTube talk show, "Uncondition Yourself with Namita," addressing critical health issues and encouraging open discussions.
- She holds a Chartered Accountant (CA) designation and an MBA from Duke University, reflecting a strong academic background that supports her leadership in the pharmaceutical industry.
- Thapar has been recognized for her contributions to the pharmaceutical sector and her efforts in promoting health education, making her a respected figure in both business and social circles.
- Through her initiatives, Thapar aims to bridge gaps in healthcare access and education, particularly focusing on women's health and wellness.
- Thapar's strategic vision for Emcure includes leveraging technology and innovation to enhance product development and improve patient outcomes.
- She has participated in various industry discussions and forums, sharing insights on the future of pharmaceuticals and the importance of sustainable practices in healthcare.
- Thapar's leadership style emphasizes collaboration and mentorship, fostering a culture of growth and development within her team at Emcure Pharmaceuticals.
- Her involvement in 'Shark Tank India' has not only elevated her profile but also inspired many aspiring entrepreneurs to pursue their business ideas with confidence.
- Thapar's commitment to social responsibility is evident through her various outreach programs aimed at improving community health and education.
- She has been featured in numerous media outlets, highlighting her journey and the impact of her work in the pharmaceutical industry and beyond.
- Thapar continues to advocate for diversity and inclusion within the business landscape, encouraging more women to take on leadership roles in various sectors.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Abbott | Senior Manager | Jan 2001 – Jan 2006 |
| EMCURE PHARMACEUTICALS LIMITED | Director | 28-Jul-2014 – 01-Aug-2014 |
| FINOLEX CABLES LIMITED | Director | 10-Aug-2015 – 25-Sep-2018 |
| FINOLEX CABLES LIMITED | Additional Director | 08-Nov-2014 – 10-Aug-2015 |
| ZUVENTUS HEALTHCARE LIMITED | Additional Director | 03-Jul-2012 – 27-Jul-2012 |
| EMCURE PHARMACEUTICALS LIMITED | CFO(KMP) | 01-Aug-2014 – 16-Apr-2021 |
| Emcure Pharmaceuticals Limited | Executive Director | Jan 2007 – Present |
| INCREDIBLE VENTURES PRIVATE LIMITED | Director | 29-Apr-2016 – Present |
| ZUVENTUS HEALTHCARE LIMITED | Director | 27-Jul-2012 – Present |
| THAPAR VISION LLP | Designated Partner | 26-Nov-2021 – Present |
| INCREDIBLE IDEAS PRIVATE LIMITED | Director | 09-Oct-2015 – Present |
| THAPAR VENTURES PRIVATE LIMITED | Director | 01-Oct-2015 – Present |
| EMCURE PHARMACEUTICALS LIMITED | Whole-time director | 01-Aug-2014 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| AAZ-6412 | THAPAR VISION LLP | Designated Partner | 26-Nov-2021 |
| U24231PN1981PLC024251 | EMCURE PHARMACEUTICALS LIMITED | Whole-time director | 01-Aug-2014 |
| U46304PN2015PTC156778 | INCREDIBLE IDEAS PRIVATE LIMITED | Director | 09-Oct-2015 |
| U74999PN2015PTC156644 | THAPAR VENTURES PRIVATE LIMITED | Director | 01-Oct-2015 |
| U74999PN2016PTC164198 | INCREDIBLE VENTURES PRIVATE LIMITED | Director | 29-Apr-2016 |
| U85320PN2002PLC018324 | ZUVENTUS HEALTHCARE LIMITED | Director | 27-Jul-2012 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| L31300MH1967PLC016531 | FINOLEX CABLES LIMITED | Additional Director | 08-Nov-2014 – 10-Aug-2015 |
| L31300MH1967PLC016531 | FINOLEX CABLES LIMITED | Director | 10-Aug-2015 – 25-Sep-2018 |
| U24231PN1981PLC024251 | EMCURE PHARMACEUTICALS LIMITED | CFO(KMP) | 01-Aug-2014 – 16-Apr-2021 |
| U24231PN1981PLC024251 | EMCURE PHARMACEUTICALS LIMITED | Director | 28-Jul-2014 – 01-Aug-2014 |
| U85320PN2002PLC018324 | ZUVENTUS HEALTHCARE LIMITED | Additional Director | 03-Jul-2012 – 27-Jul-2012 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Emcure Pharma corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Namita Thapar's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Emcure Pharma's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)